Food and Drug Administration Drug Safety Podcast
Studies show increased risk of heart rhythm problems with seizure and mental health medicine lamotrigine (Lamictal) in patients with heart disease
- Autor: Podcast
- Narrador: Podcast
- Editora: Podcast
- Duração: 0:03:00
- Mais informações
Informações:
Sinopse
Listen to an audio podcast of the March 31, 2021 FDA Drug Safety Communication that FDA review of studies show a potential increased risk of heart rhythm problems, in patients with heart disease taking lamotrigine (Lamictal). FDA requiring studies to evaluate heart risk across the drug class.
